Oncology
-
CAR-T Sales in 2023: Gilead’s Yescarta Led at $1.5 Billion as Kymriah Slipped
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Strand Life Sciences Wins Indian Patent for Blood-Based Early Cancer Detection Test
BANGALORE, July 7 — A new patented technology from Strand Life Sciences is changing how doctors look for cancer in its earliest,…
-
Emily Whitehead, First Child Given CAR T Therapy, Cancer-Free More Than Nine Years Later
PHILLIPSBURG, N.J., July 7 — In the long, often heartbreaking history of childhood cancer research, there are a handful of moments that…
-
Personalized Vaccine Plus Immunotherapy Shows Promise in Advanced Head and Neck Cancer
NEW YORK, July 5, 2026 — For families facing a cancer diagnosis, the word “immunotherapy” has become a beacon of hope. The…
-
ETH Zurich Builds Light-Controlled Switch That Wakes Dormant Lung Cancer Cells in the Lab
One number sits at the center of this new cancer research: the glucocorticoid receptor. It is a single protein. It is the…
-
US Cancer Survival Rose From 49% to 69% Since 1975, but Gains Are Uneven
NEW YORK, July 5 — For families facing a cancer diagnosis, the language of treatment can feel like a foreign country. Words…
-
Tel Aviv researchers uncover cancer growth mechanism
TEL AVIV, July 4 — Researchers at Tel Aviv University have documented a mechanism by which cancerous tumors hijack a routine immune-system…
-
Global Cervical Cancer Treatment Market to Hit $14.43B by 2034
NEW YORK, July 3 — Behind every number in a market report is a person. A mother, a sister, a friend. That’s…
-
Modified vitamin B12 compound reaches brain tumors in animal study and stays active
A modified vitamin B12 compound that sneaks past the brain’s defenses has cleared animal testing for glioblastoma. The next steps are concrete,…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
High-Fat Diet Worsens Wasting Syndrome in Mice with Lkb1 Mutation
CHICAGO — The numbers tell a grim story. In mice with lung tumors carrying a specific genetic flaw, a high-fat diet did…
-
Zenocutuzumab Gives Rare NRG1-Positive Bile Duct Cancer Patients a First Targeted Option
For the small group of patients whose bile duct cancer is driven by a specific genetic glitch, the standard treatment has been…
-
Florida A&M researchers test new drug class targeting previously untreatable pancreatic cancer
For decades, the KRAS gene was considered untouchable. A single mutation in this gene drives rapid cell division in pancreatic ductal adenocarcinoma,…
-
NYU Study Finds Lung Tumors Can Trigger Cancer Wasting Through the Vagus Nerve
For the first time, researchers have mapped a direct biological chain from a specific lung tumor mutation to the nervous system, with…
-
Nutraceutical formula shows potential in cancer treatment study
ISLAMABAD, July 1 — A new study has turned to an unexpected source in the fight against cancer: a nutraceutical formula called…
-
Medserve-LUTH Cancer Centre Named Nigeria’s Most Outstanding Oncology Centre for Fourth Year
LAGOS — The Medserve-Lagos University Teaching Hospital (LUTH) oncology partnership has retained Nigeria’s top oncology centre award for the fourth consecutive year,…
-
Global Oncology Precision Medicine Market Set for Robust Expansion Through 2031
GLOBAL — July 1, 2026 — The global market for oncology precision medicine is opening up fresh opportunities in diagnostics and therapeutics,…
-
New Analyses Link Mogamulizumab to Longer Survival in Two Rare Skin Lymphomas
PRINCETON, N.J., June 30 — New analyses are helping doctors better understand the long-term survival picture for patients with two rare forms…
-
Spanish Researcher Builds CAR-T Cells Against Rare Childhood Rhabdoid Tumours
A single gene gone wrong. That is the core problem with rhabdoid tumours. And it is the core clue that a Spanish…
-
Mindfulness Program Linked to Fewer Complications After Liver Cancer Procedure, Study Finds
HOUSTON, June 29 — A new study suggests that mindfulness-based stress reduction may improve perioperative outcomes for patients with advanced hepatocellular carcinoma…
-
Modified Vitamin B12 Compound Shows Early Promise Against Glioblastoma
For decades, the blood-brain barrier has been the graveyard of hope for glioblastoma patients. A new study suggests a modified vitamin might…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
-
Study Finds Cancers Hiding from T Cells May Be More Vulnerable to Immune Attack
For years, the logic seemed airtight. Cancer cells that stripped away a key molecular flag — MHC class I — were considered…
-
21 Virginia Cancer Specialists Physicians Named to Washingtonian Top Doctors Hall of Fame
Twenty-one oncologists at one Virginia practice have now been named to a regional hall of fame for physicians — but the real…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992